Release of recombinant human interleukin-2 from dextran-based hydrogels

Rosenberg, 1987, A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high-dose interleukin-2 alone, N. Engl. J. Med., 316, 889, 10.1056/NEJM198704093161501 Rosenberg, 1985, Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer, N. Engl. J. Med., 313, 1485, 10.1056/NEJM198512053132327 Zhang, 1996, The effect of the reconstitution medium on aggregation of lyophilized recombinant interleukin-2 and ribonuclease A, Pharm. Res., 13, 643, 10.1023/A:1016074811306 Vlasveld, 1993, Reconstitution of recombinant interleukin-2 (rhIL-2): a comparative study of various rhIL-2 muteins, Eur. J. Cancer, 29A, 1977, 10.1016/0959-8049(93)90456-P Arakawa, 1994, Structure and solubility of interleukin-2 in sodium dodecyl sulfate, Int. J. Peptide Protein Res., 43, 583, 10.1111/j.1399-3011.1994.tb00560.x Donohue, 1983, The fate of interleukin-2 after in vivo administration, J. Immunol., 130, 2203, 10.4049/jimmunol.130.5.2203 Tian, 1998, In vitro and in vivo assessment of liposomes containing recombinant human interleukin-2, Proc. Int. Symp. Control. Release Bioact. Mater., 25, 439 Koppenhagen, 1997 Matsuoka, 1988, Development of an interleukin-2 slow delivery system, Trans. Am. Soc. Artif. Intern. Organs, 34, 729 Hora, 1990, Controlled release of interleukin-2 from biodegradable microspheres, Biotechnology, 8, 755, 10.1038/nbt0890-755 Johnston, 1992, Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice, Pharm. Res., 9, 425, 10.1023/A:1015815624334 Liu, 1997, Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres, J. Controlled Release, 43, 65, 10.1016/S0168-3659(96)01471-X Egilmez, 1998, Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model, Cancer Immunol. Immunother., 46, 21, 10.1007/s002620050455 Uversky, 1997, Conformational transitions provoked by organic solvents in β-lactoglobulin: can a molten globule like intermediate be induced by the decrease in dielectric constant?, Folding Design, 2, 163, 10.1016/S1359-0278(97)00023-0 van de Weert, 2000, The effect of a water/organic solvent interface on the structural stability of lysozyme, J. Controlled Release, 68, 351, 10.1016/S0168-3659(00)00277-7 van de Weert, 2000, Protein instability in poly(lactic-co-glycolic acid) microparticles, Pharm. Res., 17, 1159, 10.1023/A:1026498209874 Wang, 1998, A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic) microspheres using agarose hydrogel, Int. J. Pharm., 166, 1, 10.1016/S0378-5173(97)00339-6 Park, 1996, Issues of implantable drug delivery systems, Pharm. Res., 13, 1770, 10.1023/A:1016012520276 Peppas, 2000, Hydrogels in pharmaceutical formulations, Eur. J. Pharm. Biopharm., 50, 27, 10.1016/S0939-6411(00)00090-4 van Dijk-Wolthuis, 1997, Degradation and release behavior of dextran-based hydrogels, Macromolecules, 30, 4639, 10.1021/ma9704018 Cadée, 2000, In vivo biocompatibility of dextran-based hydrogels, J. Biomed. Mat. Res., 50, 397, 10.1002/(SICI)1097-4636(20000605)50:3<397::AID-JBM14>3.0.CO;2-A Hennink, 1996, Controlled release of proteins from dextran hydrogels, J. Controlled Release, 39, 47, 10.1016/0168-3659(95)00132-8 Anonymous, Investigational brochure, Proleukin recombinant interleukin-2 (human), Chiron Corporation, Emeryville, USA, 1992. Fraker, 1978, Protein and cell membrane iodinations with a sparingly soluble chloroamide 1,3,4,6-tetrachloro-3α, 6α-diphenylglycolouril, Biochem. Biophys. Res. Commun., 80, 849, 10.1016/0006-291X(78)91322-0 Guide to radioiodination techniques, Iodine-125, Amersham, Life Science, UK, 1993. van Dijk-Wolthuis, 1995, Synthesis, characterization and polymerization of glycidyl methacrylate derivatized dextran, Macromolecules, 28, 6317, 10.1021/ma00122a044 van Dijk-Wolthuis, 1997, Reaction of dextran with glycidyl methacrylate: an unexpected transesterification, Macromolecules, 30, 3411, 10.1021/ma961764v van Dijk-Wolthuis, 1997, A new class of polymerizable dextrans with hydrolyzable groups: hydroxyethyl methacrylated dextran with and without oligolactate spacer, Polymer, 38, 6235, 10.1016/S0032-3861(97)00189-4 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Koppenhagen, 1998, Development of a routine analysis method for liposomes encapsulated recombinant interleukin-2, J. Chrom. B. Biomed. Sci. Appl., 716, 285, 10.1016/S0378-4347(98)00271-0 J.A. Cadée, M.J. van Steenbergen, C. Versluis, A. Heck, W.J.M. Underberg, W. den Otter, W. Jiskoot, W.E. Hennink, Oxidation of interleukin-2 by potassium peroxodisulfate, Pharm. Res., in press. Reubsaet, 1995, Degradation kinetics of antagonist [Arg6, d-Trp7,9, MePhe8]-substance P[6–11] in aqueous solutions, Anal. Biochem., 227, 334, 10.1006/abio.1995.1289 Hoitink, 1996, Degradation kinetics of gonadrolin in aqueous solution, J. Pharm. Sci., 85, 1053, 10.1021/js9601187 Bollag, 1991 Gillis, 1978, T cell growth factor: parameters of production and a quantitive microassay for activity, J. Immunol., 120, 2027, 10.4049/jimmunol.120.6.2027 Sasaoki, 1989, Oxidation of methionine residues of recombinant human interleukin-2 in aqueous solutions, Chem. Pharm. Bull., 37, 2160, 10.1248/cpb.37.2160 Ritger, 1987, A simple equation for description of solute release. I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, J. Controlled Release, 5, 23, 10.1016/0168-3659(87)90034-4 Ritger, 1987, A simple equation for description of solute release II. Fickian and anomalous release from swellable devices, J. Controlled Release, 5, 37, 10.1016/0168-3659(87)90035-6 M Kluijtmans, 1998, Self-diffusion of charged colloidal tracer spheres in transparent porous glass media: Effect of ionic strength and pore size, J. Chem. Phys., 108, 7469, 10.1063/1.476167 Shipanova-Kadiyala, 1998, Polymeric controlled delivery of IL-2 and doxorubicin against a murine melanoma model, Proc. Int. Symp. Control. Rel. Bioact. Mater., 25, 984